6505--Tacrolimus Oral Capsule (VA-20-00075581)
Closed Solicitation Posted
This opportunity was awarded. See the award notice from .
- Solicitation number
- 36E79720R0066
- Agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
Notice details come from SAM.gov. Updated .
About this opportunity
This solicitation seeks proposals for an unrestricted contract to supply tacrolimus oral capsules in 0.5mg, 1mg, and 5mg strengths to the Department of Veterans Affairs, Department of Defense, Bureau of Prisons, and Indian Health Service through their pharmaceutical prime vendor programs. The VA intends to award a single contract for a one year base period plus four one-year option periods to provide an uninterrupted supply. Proposals are due by September 2, 2020. Offerors must identify the exact drug name and unique NDC number to be supplied. If determined clinically appropriate, the awarded product will be mandatory for prescriptions, though the branded product Prograf may still be prescribed.
The estimated annual requirements total over 200,000 bottles across the three strengths, with 51,318 bottles of 0.5mg capsules, 149,210 bottles of 1mg capsules, and 5,449 bottles of 5mg capsules. The NAICS code for this procurement is 325412, pharmaceutical preparation manufacturing. There is no set-aside designation. Questions are due by August 25, 2020 and can be emailed to Adrienne A. Albachiara. Distribution will occur through the VA and DOD pharmaceutical prime vendor programs. The place of performance will be the various medical facilities those programs support.
Notice text
PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79720R0066 for an unrestrictive procurement for Tacrolimus Capsules, for the Department of Veterans Affairs (VA), Department of Defense (DOD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DOD s respective Pharmaceutical Prime Vendor Programs. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have a unique NDC number. Solicitation 36E79720R0066 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about August 11, 2020, with a tentative closing date of August 25, 2020. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at the following URL: http://www.beta.SAM.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check this URL for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Adrienne A. Albachiara. Questions can be e-mailed to: adrienne.albachiara@va.gov.
The estimated annual requirements are as follows:
ITEM
DESCRIPTION
PACKAGE SIZE (BOTTLES)
TOTAL ESTIMATED ANNUAL USAGE (BOTTLES)
1
Tacrolimus 0.5mg Capsules
100
51,318
2
Tacrolimus 1mg Capsules
100
149,210
3
Tacrolimus 5mg Capsules
100
5,449
Clinician will have the ability to continue to prescribe the branded product Prograf®; however, when Clinicians determine a generic is clinically appropriate the awarded product will be the mandatory source.
Files
| File | Type | Posted |
|---|---|---|
| 36E79720R0066 0001.docx | DOCX document | |
| 36E79720R0066.docx | DOCX document |
Notice history
| Notice | Type | Posted |
|---|---|---|
| 6505--Tacrolimus Oral Capsule (VA-20-00075581) Effective 4/1/2021 - 3/31/2022 | Award Notice | |
| This notice | Solicitation | |
| 6505--Tacrolimus Oral Capsule (VA-20-00075581) | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| 6505--Ramipril Capsules RFP | National Acquisition Center | No set-aside | |
| 6505--Sacubitril/Valsartan Tablets (VA-27-00014055) | National Acquisition Center | No set-aside | |
| 6505--Latanoprost Ophthalmic Solution (VA-27-00006027) | National Acquisition Center | No set-aside | |
| 6505--FY27 Lenalidomide BPA | Veterans Integrated Service Network 22 | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity